The Trip Report

Beckley Waves
The Trip Report

The Trip Report is a podcast and newsletter about the business, science, and policy developments of the evolving psychedelic field. While the main organizing theme is psychedelics, it is really about the many different domains that are converging to bring about this field and the assembly of what many believe to be a “New Paradigm” in science, medicine, and our understanding of the human experience. Our goal is to foster an educated and informed psychedelic ecosystem, and to do that, we will feature in-depth conversations with scientists, entrepreneurs, investors and stakeholders at the forefront of the psychedelic renaissance. www.thetripreport.com

  1. #38 Hailey Gilmore: The Complexity of Psychedelic Science

    -5 J

    #38 Hailey Gilmore: The Complexity of Psychedelic Science

    Welcome back to The Trip Report Podcast, a production of Beckley Waves. Today, I am speaking with Hailey Gilmore, the former Medical Science Liason at MAPS PBC, Lykos Therapeutics, and founder of Luminous Research Consulting Hailey joined MAPS in 2020, where she spearheaded their investigator-initiated trials (IIT) program, overseeing how MDMA-assisted therapy could address diverse clinical indications. Her role involved navigating complex regulatory landscapes, establishing protocols, and engaging with researchers worldwide. Today, as the founder of Luminous Research she leverages her expertise to guide organizations in bringing psychedelics and other innovative therapies to market. Hailey is a public health scientist with a master’s degree in epidemiology and biostatistics from UC Berkeley. She has spent over 15 years in clinical trial management, initially in the HIV prevention field, where she contributed to groundbreaking studies such as the efficacy of pre-exposure prophylaxis (PrEP) in preventing HIV transmission. This conversation is a masterclass in understanding psychedelic therapy development's nuanced challenges and opportunities. Here’s what we cover: * The Landscape of Psychedelic Therapy: Hailey breaks down the logistical hurdles of bringing MDMA-assisted therapy to market, from FDA approvals to state-by-state legislative processes and the complex interplay of insurance, healthcare institutions, and drug rescheduling. * Insights from HIV Research: Drawing parallels with PrEP’s rollout, Hailey provides a framework for how psychedelics might navigate similar adoption barriers, including clinician training, insurance buy-in, and the balancing act between small, agile clinics and large academic centers. * The Role of Smaller Clinics vs. Academic Institutions: She reflects on how smaller clinics might be better positioned to implement MDMA-assisted therapy quickly, given their flexibility, while larger institutions struggle to turn their metaphorical cruise ships. * Systemic Challenges in the Psychedelic Field: From the intricacies of DEA licensing to the limitations of current research funding, Hailey outlines the systemic barriers that continue to slow progress in this field. * Optimism Amid Complexity: Despite the delays in MDMA-assisted therapy’s approval, Hailey believes that public-private partnerships and innovative trial designs could unlock new opportunities for psychedelic research and implementation. Finally, we explore the potential impact of Robert F. Kennedy Jr.'s potential appointment as Secretary of Health and Human Services in the Trump administration. Could this mark a turning point for federal policy on psychedelics? Hailey weighs the possibilities and shares her vision for how public health could guide this evolving conversation. And now, I bring you my conversation with Hailey Gilmore. Listen to the episode on Substack, Spotify, Google or Apple. Credits: * Hosted by Zach Haigney * Produced by Zach Haigney, Erin Greenhouse, and Katelin Jabbari * Find us at thetripreport.com * Follow us on Instagram, Twitter, LinkedIn and YouTube Theme music by MANCHO Sounds, Mixed and Mastered by Rollin Weary This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.thetripreport.com

    1 h 2 min
  2. #37 Dr. James Cooke: The Dawn of Mind: How Matter Became Conscious and Alive

    12 DÉC.

    #37 Dr. James Cooke: The Dawn of Mind: How Matter Became Conscious and Alive

    Welcome back to The Trip Report Podcast, a production of Beckley Waves. Today, we are speaking with Dr. James Cooke, neuroscientist, philosopher, and author of the recently released book, Dawn of Mind: How Matter Became Conscious and Alive. This groundbreaking work offers a bold new perspective on the nature of consciousness, bridging the gap between science and spirituality, and challenging conventional paradigms about mind, matter, and the fabric of experience itself. In Dawn of Mind, James explores the "hard problem" of consciousness through the lens of his Living Mirror Theory, which proposes that consciousness arises as a relational process intrinsic to all living systems. The book deftly synthesizes insights from neuroscience, philosophy, and contemplative traditions to offer a compelling framework for understanding subjective experience, suffering, and the relief of suffering. It also challenges readers to reconsider the boundaries between self and world and between the physical and experiential realms. Our conversation today is a tour through: * The Living Mirror Theory and its implications for understanding consciousness as a fundamental aspect of life. * The journey behind Dawn of Mind, including how James’ spontaneous mystical experience at age 13 catalyzed his lifelong inquiry into the nature of reality. * How somatic practices align with his theory and provide a direct pathway to healing and insight. * The synthesis of modern neuroscience and ancient contemplative traditions, creating a holistic view of the mind and its place in the universe. * And much more. And now, I bring you my conversation with James Cooke. Listen to the episode on Substack, Spotify, Google or Apple. Credits: * Hosted by Zach Haigney * Produced by Zach Haigney, Erin Greenhouse, and Katelin Jabbari * Find us at thetripreport.com * Follow us on Instagram, Twitter, LinkedIn and YouTube Theme music by MANCHO Sounds, Mixed and Mastered by Rollin Weary This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.thetripreport.com

    1 h 19 min
  3. #36 Dillan DiNardo: Engineering Consciousness with Psychedelics and AI

    29 NOV.

    #36 Dillan DiNardo: Engineering Consciousness with Psychedelics and AI

    Before we dive in, please fill out the below brief reader survey—it takes 60 seconds—to help us better understand what you like and would like to see more of from The Trip Report in 2025! Welcome back to The Trip Report Podcast, a production of Beckley Waves. Today, I am speaking with Dillan DiNardo, CEO of Mindstate Design Labs, an innovative drug development company taking a unique approach to developing next-generation psychedelic medicines. Mindstate's approach builds on the legacy of Sasha and Ann Shulgin, the pioneering chemists often referred to as the godparents of psychedelics. The company's scientific foundation comes from Dr. Tom Ray, a polymath scientist and friend and collaborator of the Shulgins. What makes Mindstate's approach unique is its systematic analysis of both pharmacological and phenomenological data—studying not just how drugs interact with receptors in the brain, but also the subjective experiences they produce. This builds on decades of carefully documented experiences from psychonauts around the world. The company is developing what they call a "primer-probe" approach, using carefully selected combinations of compounds to achieve specific experiential effects. Their lead candidate, Moxie (MSD-1), recently received FDA clearance to begin human trials. Dillan comes to this work with a background in biotech venture capital, bringing a pragmatic approach to drug development while embracing the complexity and potential of psychedelic medicines. In this conversation, we discuss: * The origin story of Mindstate and their novel approach to drug development * How they analyze and quantify subjective psychedelic experiences * Their "primer-probe" methodology using drug combinations * The concept of "psychedelic tofu" - compounds that can amplify or modify other psychedelic effects * Their vision for precision-designed altered states of consciousness * The regulatory pathway for combination psychedelic medicines * The broader implications of their research for understanding consciousness And now, I bring you my conversation with Dillan DiNardo. Listen to the episode on Substack, Spotify, Google or Apple. Credits: * Hosted by Zach Haigney * Produced by Zach Haigney, Erin Greenhouse, and Katelin Jabbari * Find us at thetripreport.com * Follow us on Instagram, Twitter, LinkedIn and YouTube Theme music by MANCHO Sounds, Mixed and Mastered by Rollin Weary This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.thetripreport.com

    41 min
  4. Special Dispatch: Regulatory Plasticity with Matt Zorn

    19 NOV.

    Special Dispatch: Regulatory Plasticity with Matt Zorn

    Welcome to another Special Dispatch from The Trip Report Podcast, a production of Beckley Waves.  Today, I am speaking with Matt Zorn, a litigator and partner at Yetter Coleman. With a practice spanning antitrust, competition, IP, and a deep focus on controlled substances and drug regulation, Matt brings a unique perspective to the shifting landscape of drug policy and health agency reform. What makes this discussion especially relevant today is the backdrop of the recent political realignment in the U.S., with RFK Jr.’s role within a Trump administration and the Make America Healthy Again (MAHA) initiative looming over the political landscape. As a result, we find ourselves at a unique inflection point to reassess drug policy and, perhaps, a pivotal moment of mental health, psychedelics, and regulatory processes. Matt’s insights don’t shy away from the complex history and challenges facing the psychedelic movement and broader healthcare reform. He argues that the FDA’s structure itself may not be fit for purpose in modern mental health treatment. In our conversation, we explore: * The origins and inefficiencies of current drug regulation processes. * Why the Controlled Substances Act and FDA efficacy requirements may hinder real-world applications. * How reforming clinical trial processes or even fundamentally changing statutory requirements could reshape the space. * Concrete ideas for reforming the system, including lessons drawn from MDMA’s recent regulatory struggles. * How drug development pathways intertwine with controlled substances law, patent incentives, and the broader economic landscape of pharmaceuticals. Without further ado, I bring you my conversation with Matt Zorn. Listen to the episode on Substack, Spotify, Google or Apple. Credits: * Hosted by Zach Haigney  * Produced by Zach Haigney, Erin Greenhouse, and Katelin Jabbari * Find us at thetripreport.com * Follow us on Instagram, Twitter, LinkedIn and YouTube Theme music by MANCHO Sounds, Mixed and Mastered by Rollin Weary This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.thetripreport.com

    1 h 1 min
  5. Special Dispatch: An Election Retrospective with Nick Gillespie

    13 NOV.

    Special Dispatch: An Election Retrospective with Nick Gillespie

    Welcome to a Special Dispatch of The Trip Report Podcast, a production of Beckley Waves. Today, I’m joined by Nick Gillespie, Editor-at-Large of Reason magazine, to discuss the results of the US election and specifically what it might mean for psychedelic policy, research, and drug development.   As a veteran observer of the intersection between politics, regulation, and civil liberties, Nick offers a unique lens through which to examine the evolving dynamics of psychedelics, the regulatory state, and how the incoming Trump administration might approach the matter. Our conversation focuses on the curious coalition between former presidential candidate Robert F. Kennedy Jr. and President-Elect Donald Trump, who has said he will let Kennedy “go wild on health” through a yet-to-be-announced position in his administration.  This partnership raises critical questions about the potential for sweeping changes to policy in the United States—particularly as it relates to psychedelics, alternative therapies, and broader health reforms. We explore the paradoxical nature of this political moment, in which historical stigmas are shifting, and new coalitions are forming.  With drug policy historically defined by prohibition, could we now be on the verge of a psychedelic renaissance fueled by executive power and bipartisan pragmatism?  We unpack the complexities of de-scheduling psychedelics, the implications of potential federal support for therapeutic use, and how the cultural, medical, and regulatory terrain could evolve. In typical fashion, Nick brings clarity and insight to a conversation that touches on the FDA's recent rejection of MDMA-assisted therapy, the mixed outcomes of state-level psychedelic ballot initiatives, and the broader cultural shifts that frame America's approach to mental health, addiction, and drug legalization. This is a moment where history, politics, and the psychedelic renaissance converge—an era brimming with opportunity and risk, with the potential for substantive change at hand. Without further ado, I bring you my conversation with Nick Gillespie. Listen to the episode on Substack, Spotify, Google or Apple. Credits: * Hosted by Zach Haigney  * Produced by Zach Haigney, Erin Greenhouse, and Katelin Jabbari * Find us at thetripreport.com * Follow us on Instagram, Twitter, LinkedIn and YouTube Theme music by MANCHO Sounds, Mixed and Mastered by Rollin Weary This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.thetripreport.com

    41 min
  6. #35 Lucia Huang: Innovative Solutions in Neuropsychiatry

    31 OCT.

    #35 Lucia Huang: Innovative Solutions in Neuropsychiatry

    Happy Halloween! 🎃 Welcome back to The Trip Report, a production of Beckley Waves. In this episode, we’re joined by Lucia Huang, Co-Founder and CEO of Osmind, a mental health startup that seeks to transform psychiatry by supporting clinicians with a novel treatment and research platform that streamlines measurement-based care. Measurement-based care in mental health is a clinical approach that relies on systematically tracking and analyzing patient-reported outcomes and objective data to guide treatment decisions. In measurement-based care, symptoms, such as mood, sleep, and other physical health indicators, are monitored over time. This continuous feedback allows clinicians to personalize care, adjust treatments as needed, and make data-driven decisions to improve outcomes. However, streamlining this process has been a challenge.  Osmind sees to make this process easier for the field of psychiatry as they adopt innovative treatments like Transcranial Magnetic Stimulation, Spravato, ketamine and other emerging tools. In our conversation, we explore: * The founding story of Osmind and the inspiration drawn from Lucia’s own life and career in healthcare * How interventional psychiatry is poised to change the landscape of mental health treatment * The promise and challenges of incorporating biomarkers and real-world evidence into psychiatric care * And her vision for a future where psychiatry embraces precision medicine and autonomy for clinicians And now, I bring you my conversation with Lucia Huang. Interested in working with The Trip Report or Beckley Waves? Get in touch! We’re always looking for passionate individuals and organizations to collaborate. If you're interested in joining us on this journey, please contact us to explore potential partnerships, investment, and consulting opportunities or to learn more about our work. Listen to the episode on Substack, Spotify, Google or Apple. Credits: * Hosted by Zach Haigney  * Produced by Zach Haigney, Erin Greenhouse, and Katelin Jabbari * Find us at thetripreport.com * Follow us on Instagram, Twitter, LinkedIn and YouTube Theme music by MANCHO Sounds, Mixed and Mastered by Rollin Weary This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.thetripreport.com

    47 min
  7. #34 Shamil Chandaria: Computational Neuroscience and Human Flourishing

    17 OCT.

    #34 Shamil Chandaria: Computational Neuroscience and Human Flourishing

    Welcome back to The Trip Report Podcast, a production of Beckley Waves. Today's conversation is with Shamil Chandaria, and as I alluded to in last week’s newsletter introducing computational neuroscience—it is the longest and most technical conversation we’ve had to date. I have wanted to speak with Shamil since I watched his lecture at Oxford titled The Bayesian Brain and Meditation. Shamil is a former advisor to Google DeepMind, co-foudner and research fellow at Imperial College London Centre for Psychedelic Research and Oxford University’s Centre for Eudaimonia and Human Flourishing, and a co-author with Robin Carhart-Harris and the Imperial team of the influential 2023 paper titled Canalization and Plasticity in Psychopathology,  Importantly for this conversation, Shamil is also a longtime meditation practitioner, and his current work is dedicated to exploring contemplative practices, spiritual awakening, and psychedelics through the lens of computational neuroscience.  At the heart of the conversation is the Free Energy Principle, a relatively new concept in cognitive neuroscience that conceives of the brain as a prediction machine constantly updating its internal models to minimize prediction errors. This framework along with the Bayesian Brain Hypothesis show how the brain optimally processes sensory data through inference, which has profound implications for how we perceive and experience the world. We discuss: * The brain as a prediction machine * The convergence of ancient wisdom and modern neuroscience. * Defining human flourishing beyond the absence of suffering to include meaning, love, joy, connection, and psychological resilience. * The role of body sensations, emotions, and somatic practices in psychotherapy and how they tie into the brain's predictive coding mechanisms. * Spiritual awakening, liberation and human flourishing through a neurocomputational lens * The potential for integrating free energy principle-based models into the field of psychiatry, improving therapeutic approaches and mental health care. * And much more My takeaway from this conversation is that we are, in fact, in the midst of a paradigm shift—one that bridges the fields of meditation, psychology, psychedelics, phenomenology, psychiatry, and even artificial intelligence.  This new understanding, grounded in the free energy principle, offers a unified theory that links ancient wisdom with modern neuroscience, reshaping how we think about consciousness, well-being, and what it means to be sentient. And now, I bring you my conversation with Shamil Chandaria. I want to highlight our friends at the Tiny Blue Dot Foundation (TBD), who have just announced their latest Request for Proposals for scientific studies of the Perception Box. Tiny Blue Dot Foundation strives to help people understand that they live in their own unique Perception Box whose walls can be expanded to minimize suffering, increase acceptance of self and others, and view trauma and other challenges as opportunities for growth. TBD has allocated $9,000,000 to fund up to 10 rigorous research projects related to The Science of the Perception Box.  TBD ran similar RFPs over the last two years and funded a total of 23 projects thus far. Information about these projects can be found here and here. Listen to the episode on Substack, Spotify, Google or Apple. Credits: * Hosted by Zach Haigney  * Produced by Zach Haigney, Erin Greenhouse, and Katelin Jabbari * Find us at thetripreport.com * Follow us on Instagram, Twitter, LinkedIn and YouTube Theme music by MANCHO Sounds, Mixed and Mastered by Rollin Weary This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.thetripreport.com

    1 h 47 min
  8. #33 Rock Feilding-Mellen: Building the Future of the Psychedelic Field

    3 OCT.

    #33 Rock Feilding-Mellen: Building the Future of the Psychedelic Field

    Welcome back to The Trip Report Podcast, a production of Beckley Waves, a Psychedelic Venture Studio. Over the past year, we’ve spoken with researchers, entrepreneurs, investors, and practitioners who are pioneering new paths in the world of psychedelics and mental health.  After over thirty episodes of The Trip Report Podcast, I figured it was time to give a peek behind the scenes of Beckley Waves and our work to support the developing field. To that end, today, I am speaking with Rock Feilding-Mellen, a co-founder and partner at Beckley Waves. In this episode, we’ll pull back the curtain on our ongoing projects, the ups and downs of building in a young and misunderstood industry, and the vision that drives our work to create meaningful change in this emerging field. In this conversation, we discuss: * Amanda Feilding and her pioneering work to support psychedelic science and drug policy reform through the Beckley Foundation * The origin story of Beckley Waves and its mission to develop a new paradigm of care delivery in the field of psychedelics. * Rock's personal journey with psychedelic-assisted therapy and how it shaped his vision for integrating these practices into mainstream healthcare. * The crucial role of supportive care in psychedelic therapy, emphasizing the importance of preparation, integration, and ongoing support. * The Beckley Waves family of companies including Beckley Retreats, Beckley Academy, and the recent acquisition of Nue Life. * The challenges and opportunities of building care delivery infrastructure for a future that includes psychedelics as a key tool for healing and thriving. And now, I bring you my conversation with Rock Feilding-Mellen. Listen to the episode on Substack, Spotify, Google or Apple. Credits: * Hosted by Zach Haigney  * Produced by Zach Haigney, Erin Greenhouse, and Katelin Jabbari * Find us at thetripreport.com * Follow us on Instagram, Twitter, LinkedIn and YouTube Theme music by MANCHO Sounds, Mixed and Mastered by Rollin Weary This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.thetripreport.com

    45 min

Notes et avis

4,9
sur 5
10 notes

À propos

The Trip Report is a podcast and newsletter about the business, science, and policy developments of the evolving psychedelic field. While the main organizing theme is psychedelics, it is really about the many different domains that are converging to bring about this field and the assembly of what many believe to be a “New Paradigm” in science, medicine, and our understanding of the human experience. Our goal is to foster an educated and informed psychedelic ecosystem, and to do that, we will feature in-depth conversations with scientists, entrepreneurs, investors and stakeholders at the forefront of the psychedelic renaissance. www.thetripreport.com

Vous aimeriez peut‑être aussi

Pour écouter des épisodes au contenu explicite, connectez‑vous.

Recevez les dernières actualités sur cette émission

Connectez‑vous ou inscrivez‑vous pour suivre des émissions, enregistrer des épisodes et recevoir les dernières actualités.

Choisissez un pays ou une région

Afrique, Moyen‑Orient et Inde

Asie‑Pacifique

Europe

Amérique latine et Caraïbes

États‑Unis et Canada